A Retrospective Cohort Study Evaluating the Safety and Efficacy of Sequential versus Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection
Table 2
Clinical characteristics of pleural infection ().
Hospital-acquired infection
19 (14.1)
Right-sided pleural effusion
82 (60.7)
Size of pleural effusion based on radiographic imaging
Small (<1/3 hemithorax)
11 (8.2)
Moderate (1/3 to 2/3 hemithorax)
62 (45.9)
Large (>2/3 hemithorax)
62 (45.9)
CT or ultrasonographic evidence of pleural loculations
124 (91.9)
Pleural fluid appearance
Serous or turbid
70 (51.9)
Hemoserous
38 (28.1)
Purulent
27 (20.0)
Gram stain/culture-positive pleural fluid
54 (40.0)
Gram stain/culture-positive pleural fluid or blood
62 (45.9)
Bacteremia
10 (7.4)
Pleural fluid characteristics
Lactate dehydrogenase (IU/L)
2225 (982-4313)
Glucose (mmol/L)
3.0 (0.6-4.9)
Peripheral leukocyte count (×109/L)
15.2 (10.7-19.6)
C-reactive protein (mg/L)
197 (129-288)
RAPID score
3 (2-4)
Low risk (0-2)
50 (37.0)
Medium risk (3, 4)
56 (41.5)
High risk (5–7)
29 (21.5)
Data are presented in number (percentage) and median (interquartile range) for categorical and continuous variables, respectively. CT: computed tomography.
